LINCOLN PHARMACEUTICALS LTD.
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- ₹491
- Today's High:
- ₹540.1
- Open Price:
- ₹530.15
- 52W Low:
- ₹273.7
- 52W High:
- ₹456.05
- Prev. Close:
- ₹533.8
- Volume:
- 55341
Company Statistics
- Market Cap.:
- ₹8.13 billion
- Book Value:
- Revenue TTM:
- ₹0
- Operating Margin TTM:
- 0%
- Gross Profit TTM:
- ₹2.00 billion
- Profit Margin:
- 0%
- Return on Assets TTM:
- 0%
- Return on Equity TTM:
- 0%
Company Profile
LINCOLN PHARMACEUTICALS LTD. had its IPO on under the ticker symbol LINCOPH.
The company operates in the sector and industry. LINCOLN PHARMACEUTICALS LTD. has a staff strength of 0 employees.
Stock update
Shares of LINCOLN PHARMACEUTICALS LTD. opened at ₹530.15 at the start of the last trading session i.e. 2023-09-13.
The stocks traded within a range of ₹491 - ₹540.1, and closed at ₹499.9.
This is a -6.35% slip from the previous day's closing price.
A total volume of 55,341 shares were traded at the close of the day’s session.
In the last one week, shares of LINCOLN PHARMACEUTICALS LTD. have slipped by -3.46%.
LINCOLN PHARMACEUTICALS LTD.'s Key Ratios
LINCOLN PHARMACEUTICALS LTD. has a market cap of ₹8.13 billion, indicating a price to book ratio of 1.4954 and a price to sales ratio of 1.4521.
In the last 12-months LINCOLN PHARMACEUTICALS LTD.’s revenue was ₹0 with a gross profit of ₹2.00 billion and an EBITDA of ₹0. The EBITDA ratio measures LINCOLN PHARMACEUTICALS LTD.'s overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, LINCOLN PHARMACEUTICALS LTD.’s operating margin was 0% while its return on assets stood at 0% with a return of equity of 0%.
In Q1, LINCOLN PHARMACEUTICALS LTD.’s quarterly earnings growth was a positive 0% while revenue growth was a positive 0%.
LINCOLN PHARMACEUTICALS LTD.’s PE and PEG Ratio
- Forward PE
- 0
- Trailing PE
- 15.0518
- PEG
Its diluted EPS in the last 12-months stands at ₹0 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into LINCOLN PHARMACEUTICALS LTD.’s profitability.
LINCOLN PHARMACEUTICALS LTD. stock is trading at a EV to sales ratio of 1.2171 and a EV to EBITDA ratio of 5.7074. Its price to sales ratio in the trailing 12-months stood at 1.4521.
LINCOLN PHARMACEUTICALS LTD. stock pays annual dividends of ₹1.5 per share, indicating a yield of 0.37% and a payout ratio of 4.98%.
Balance sheet and cash flow metrics
- Total Assets
- ₹5.87 billion
- Total Liabilities
- ₹722.84 million
- Operating Cash Flow
- ₹0
- Capital Expenditure
- ₹0
- Dividend Payout Ratio
- 4.98%
LINCOLN PHARMACEUTICALS LTD. ended 2024 with ₹5.87 billion in total assets and ₹0 in total liabilities. Its intangible assets were valued at ₹5.87 billion while shareholder equity stood at ₹5.02 billion.
LINCOLN PHARMACEUTICALS LTD. ended 2024 with ₹0 in deferred long-term liabilities, ₹722.84 million in other current liabilities, in common stock, ₹0 in retained earnings and ₹0 in goodwill. Its cash balance stood at ₹50.52 million and cash and short-term investments were ₹0. The company’s total short-term debt was ₹0 while long-term debt stood at ₹0.
LINCOLN PHARMACEUTICALS LTD.’s total current assets stands at ₹3.67 billion while long-term investments were ₹0 and short-term investments were ₹1.21 billion. Its net receivables were ₹1.36 billion compared to accounts payable of ₹511.53 million and inventory worth ₹700.28 million.
In 2024, LINCOLN PHARMACEUTICALS LTD.'s operating cash flow was ₹0 while its capital expenditure stood at ₹0.
Comparatively, LINCOLN PHARMACEUTICALS LTD. paid ₹0.05 in dividends in 2024.
Other key metrics
- Current Trading Price
- ₹499.9
- 52-Week High
- ₹456.05
- 52-Week Low
- ₹273.7
- Analyst Target Price
- ₹
LINCOLN PHARMACEUTICALS LTD. stock is currently trading at ₹499.9 per share. It touched a 52-week high of ₹456.05 and a 52-week low of ₹456.05. Analysts tracking the stock have a 12-month average target price of ₹.
Its 50-day moving average was ₹453.72 and 200-day moving average was ₹385.51 The short ratio stood at 0 indicating a short percent outstanding of 0%.
Around 0% of the company’s stock are held by insiders while 0% are held by institutions.